Unlike the highly polymorphic major histocompatibility complex (MHC) class Ia molecules, which present a wide variety of peptides to T ceils, it is generally assumed that the nonpolymorphic MHC class Ib molecules may have evolved to function as highly specialized receptors for the presentation of structurally unique peptides. However, a thorough biochemical analysis of one class Ib molecule, the soluble isoform of Qa-2 antigen (H-2SQ7b), has revealed that it binds a diverse array of structurally similar peptides derived from intracellular proteins in much the same manner as the classical antigen-presenting molecules. Specifically, we find that SQ7 b molecules are heterodimers of heavy and light chains complexed with nonameric peptides in a 1:1:1 ratio. These peptides contain a conserved hydrophobic residue at the COOH terminus and a combination of one or more conserved residue(s) at P7 (histidine), P2 (glutamine/leucine), and/or P3 (leucine/asparagine) as anchors for binding SQ7 b. 2 of 18 sequenced peptides matched cytosollc proteins (cofilin and L19 ribosomal protein), suggesting an intraceUular source of the SQ7 b ligands. Minimal estimates of the peptide repertoire revealed that at least 200 different naturally processed self-peptides can bind SQ7 b molecules. Since Qa-2 molecules associate with a diverse array of peptides, we suggest that they function as effective presenting molecules of endogenously synthesized proteins like the class Ia molecules.
T
he MHC class I molecules serve as receptors for the transport and display of endogenously derived self-and nonsdf-peptides at the cell surface. Non-sdf-peptides (e.g., derived from intracenular pathogens), when presented by class I molecules, form ligands for TCRs triggering antigen-specific lysis of the infected cells by CTL (reviewed in reference 1). The presentation of self-and non-self-peptides is attributed to the ubiquitously expressed, highly diverse classical transplantation antigens known as the class Ia molecules, which in the mouse are encoded by the H-2K and D region genes. The diversity of the class Ia molecules mainly affects the antigen binding groove, which is thought to be important for presenting a wide variety of peptides for immune surveillance by T cells (2) . It is intriguing, however, that the majority of the class I genes in the mouse MHC (>30) distributed over the H-2Q, T, and M regions are not polymorphic. Their products, known as the nonclassical class Ib molecules, compared with the class Ia molecules are highly conserved, are expressed in a tissue specific manner, and their physiological role(s) is unknown (3, 4) .
Several recent studies have shown that H-2Q, T, and M molecules can serve as weak transplantation antigens in vivo and in vitro (3) (4) (5) (6) . Further, they can also present intracellular pathogen-derived antigens to specific CTL (7) (8) (9) (10) (11) . In several instances, the CTL responses are peptide dependent (7) (8) (9) (12) (13) (14) (15) (16) , suggesting that one of the physiological functions of class Ib molecules might be to control immune responses to intracellular pathogens akin to the class Ia molecules. Since, the antigen binding grooves of the class Ib molecules are highly conserved, it is often thought that they may have evolved to present a limited set of unique peptides. This has been shown to be true for H-2M3 molecule, which requires an N-formylated peptide for binding, a feature present only in 13 mitochondrial (sdf)-proteins (7, 8, (12) (13) (14) (15) (16) . Whether this is a general feature for class Ib binding peptides is not known.
Qa-2 antigens are among the best characterized class Ib molecules. Encoded by two almost identical genes, Q7 and Q9 in the b haplotype mice, they are expressed on lymphoid cells and primitive hematopoietic progenitors in the bone marrow in adult mice (17) . They are noncovalently assodated with/3z-microglobulin (/32-m) 1 and exist in vivo in two forms: the 40-kD Qa-2 antigen anchored to the membrane by glycophosphatidylinositol (GPI) (8, 19) and the 39-kD soluble molecule (20) , SQa-2. The switch from membranebound to soluble form is induced upon activation of the immune system and is thought to play a role in the regulation of the immune response (20, 20a) .
In an approach to solve the major puzzle as to the role of the numerous nonpolymorphic MHC class Ib molecules, we have analyzed the biochemical features of the soluble isoform of Qa-2 antigen, SQ7 b. We find that SQ7 b molecules consist of heavy and light chains complezed with nonameric peptides in 1:1:1: ratio. These peptides contain a Q7b-specific binding motif and are derived from intracdlular proteins. These data and the minimal estimates of SQ7 b binding peptide repertoire support the conclusion that Qa-2 molecules bind a diverse array of naturally processed peptides in much the same manner as the highly polymorphic MHC class Ia molt'ales.
Materials and Methods
High Expression CeULine. Large quantities of SQa-2 complexes were produced in NS0 myeloma cells using pHEKmDHFR vectorbased expression system (21) . The eDNA encoding SQ7 b (20) was cloned into the SalI site of pHEKmDHFK downstream from the immunoglobulin heavy chain enhancer and K chain promoter splice site cassette (Fig. 1) to ensure efficient expression of the recombinant eDNA. The eDNA differs at two positions from the reported sequence (22; and Coy'arts, E. C., and S. G. Nathenson, unpublished results); their location does not affect the peptide binding groove nor ~z-m interaction. Downstream from the eDNA is the 3' end of the g constant region and its polyadenylation site. The vector also contains a DNA amplification selection marker, mutant dihydrofohte reductase, which binds methotrexate (Mtx) poorly such that the transfected cells can be selected in concentrations of Mtx that would be normany lethal to the cells. Genes expressed in this manner in the pHEKmDHFR vector have been shown to be coamplified, resulting in high expression of the recombinant protein in myeloma cells (21) . The recombinant pHEKmDHFKsQ7b plasmid was introduced into NS0 cells by dectroporation. Mtx-resistant transfectants were selected in DMEM supplemented with 5% FCS and 0.2/xM Mtx. The transfected pool was subjected to increasing concentrations of Mtx over a period of few months essenthlly as described by Hendricks et al. (21) . Cens resistant to 10/~M Mtx were cloned and SQ7 b high expressors were identified by F, LISA. Selected clones were then cultured with increasing concentrations of/vim. The highest SQ7 b secreting done resistant to 64 p2r of Mtx was grown in a CdliGenTM-stirred tank bioreactor (New Brunswick Sci., Edison, NJ) in 1:1 DMEM/RPMI supplemented with 3% FCS, 1 mM sodium pyruvate, 0.01% pluronic I:.66, and 0.6/~M Mtx. Under these conditions, the cells 1 Abbreviations used in this paper." ~z-m, ~Sz-microglobulin; Mtx, methotrexate; RP, reversed phase. grown with agitation of 40 rpm produced up to 10 mg of SQ7b/10 liters of tissue culture-spent medium over a period of 2-5 d. The spent medium thus obtained was used for SQ7 b and peptide analysis.
ELISA. ELISA was performed by a modification of the method described by Harlow and Lane (23) . Briefly, polyginyl chloride 96-well phtes were coated with Qa-2-specific affanity-purifaed mAb M46 (24) . The uncoupled sites were blocked with 3% BSA diluted in PBS, pH 7.4. Tissue culture supernatants containing SQ7 b or purified SQ7 b in PBS were added to the wells and incubated overnight at 4~ Supernatants from the wells were aspirated and the wells were washed three times with 0.5% Tween-20 in PBS (PBS/Tween). Biotinylated Qa-2-specitic mAb 20-8-4s (25) was added to the SQ7b-coated wells and incubated for 4 h at 4~ The plates were washed six times with PBS/Tween. The reaction was amplified with ~-galactosidase-conjugated strepta~din (Boehringer Mannheim Biochemicals, Indianapolis, IN) for 30 rain at 4~ washed six times as above, and devdoped using the ~-galactosidase substrate red-~-D-galactopyranoside (Boehringer Mannheim Biochemicals). The concentration of SQ7 b in the superuatants was estimated by recording absorbance of the red product at 570 nm using a microtiter plate reader (Bio-Tck Instrs., Winooski, VT).
Affinity Chromatography. SQ7 b molecules were purified from culture superuate ofNS0 transfectants. The supernate was first concentrated to 1:10 the volume by saturated ammonium sulfate precipitation (final concentration of 80%). The concentrate was quantitared using conformation-dependent mAb 20-8-4s and M46 in an ELISA (data not shown). The SQ7 b was affinity purified using 3.2 m120-8-4s-coupled protein A-Sepharose column. Affanity cohmns were prepared by coupling the protein A (Pharmacia LKB, Gaithersburg, MD)-purified antibody to protein A-Sepharose using dimethyl pimelimidate-2 HCI (Pierce, Rockford, IL) as described by Harlow and Lane (23) . The concentrate (120 ml) was passed over normal mouse serum, B22-249 (D b specific; 26), and 20-8-4s columns, in that order, once at the rate of 0.5 ml/min. The B22-249 and 20-8-4s columns were washed with 20-column volumes of PBS and duted with 5 ml of 0.1 N acetic acid (pH 2.9); the first 1 ml was discarded and the next 4.5 ml was collected. The ehted materials were denatured by increasing the concentration of acetic acid to 2.0 N (pH 1.96) followed by incubation of the mixture in a boiling water bath for 5 rain. The mixture was cooled for 15 min at room temperature. A 100-/~1 aliquot was used for amino acid analysis and another 100/~1 was subjected to amino acid sequence analysis. Data from both these analyses were used to quantitate the initial amount of SQ7 b molecuhs. Peptides from 4.0 ml of the denatured material were separated by centrifugation using a Centricon 3 filtration unit (Amicon Corp., Danvers, MA). The filtrate so obtained is the acid-cluted fraction. The acid-eluted fraction was concentrated to 120/~1 in a speed-vac (Savant Instrs., Inc., Farmiagdale, NY), of which 10% was used to quantitate peptide yield by amino acid analysis.
Reuersed-Phase (RP) HPLC. The remainder of the acid-ehted ultrafiltrate (90%; ~2.7 nmol) was loaded onto a 1.0 x 250-ram nucleosil C18 column (Alhech Assoc. Inc., Deerfidd, IL) and separated by ILP-HPI,C using HFI090 (Hewlett-Packard Co., Palo Alto, CA) equipped with an on-line 1040 diode array detector. The column was eluted using 0.06% tn'fluoroacetic acid, 5% acetonitrile, water (buffer A) and 0.05% triiluoroacetic acid, 80% acetonitrih, water (buffer B). The gradient of the mobile phase consisted of 0% B at start (0.01 min), 37% B at 63 rain, 70% B at 95 min, 90% B at 105 min, and 100% B at 110 min, established at a rate of 75/zl/min. Chromatographic data was acquired at 210 and 280 nm. Eluting peaks were monitored at 210 nm and individual peaks were manually collected after a hg time of 0.2 min. Each fraction was quick frozen on dry ice and stored at -70~ until further use. Repurification of individual peaks was performed essentially as above. The dution gradient consisted of either of two conditions: peaks 3, 5, 7, 10, and 19 were purified using 0% B at start (0.01 min), 37% B at 63 min, and 100% B at 70 min, at a flow rate of 50/zl/min; the remainder of the peaks were repurified using 20% B at 10 rain, 45% B at 70 min, and 100% B at 75 rain, at a flow rate of 50 /~l/min. Peptide preparation from B22-249 column-ehted material was separated by RP-HPLC using the first gradient. The chromatogram so obtained was used to determine the specific peaks obtained from peptides eluted from SQ7 b.
Amino Acid Analysis and Sequencing. The peptide or protein preparations were acid hydrolyzed in 6 N HC1 in sacuo at 110~ for 24 h. The hydrolysate was speed-sac concentrated and made to 6/~1 in distilled water. A fraction (1 #1) was analyzed using HP AminoQuant (Hewlett-Packard Co.) system with o-phthahldehyde and f-moc precolumn derivatization. Fluorescence data was collected using an HP 1046 detector (Hewlett-Packard Co.). Quantiration of the affinity-purified SQ7 b complex using the yields of alanine (n = 27.5), arginine (n = 25.5), histidine (n = 14), and leucine (n = 31.5) from the amino acid analysis data resulted in 5.75 nmol of the starting material from 120 ml of crude concentrate. A similar analysis of the acid-eluted ultrafxltrate yielded 3.03 nmol of peptides using the yields of histidine and leucine as the common insariant residues in the peptide after correcting for nonspecific background. The background for this analysis was determined as the amount of histidine and leucine present in the ultraffltrate of the material duted from B22-249 (isotype-matched nonspedfic mAb) column.
Amino acid sequencing was performed by automated Edman degradation (AB1477A; Applied Biosystems, Inc., Foster City, CA). The arginine residues in the heavy chain of SQ7 b were ascertained by sequence analysis using a Porton 2000 sequencer (Beckman Instrs., Fullerton, CA).
A data base search was performed to compare the peptide sequences obtained with those stored in the Swiss Protein Data Bank (SwissProt release 25.0; 4/93) using the Wisconsin Genetics Computer Group (GCG) sequence analysis package (27) .
Results

~~
~$~-2 Mo~ in Mammal~n Gdk Sin~ Qa-2 molecules are expressed in vivo as a heterogeneous mixture of products of several related genes in relatively low quantities (28), we have developed a genetically engineered cell line producing high levels of a single Qa-2 product, SQ7 b. Full-size eDNA encoding SQ7 b (20) was subdoned into the pHEKmDHFR vector (21), introduced into NS0 cells by electroporation, and selected by stepwise methotrexate treatment (Fig. 1 ). NS0 cells (GPI-and SQa-2-negative BALB/c-derived myeloma) were used so that the host cell producing the recombinant protein will be closely related to the cells expressing Qa-2 in vivo, which is important in the analysis of endogenous sdf-peptides. The highest SQa-2-secreting clones were estimated to produce "~0. tegrity of the SQ7 b molecules in the concentrate when tested by ELISA using a conformation-dependent mAb showed no loss of SQ7 b structure. SQ7 b molecules were further purified by affinity chromatography using 20-8-4s mAb and the resulting Qa-2 proteins were tested by SDS-PAGE (data not shown) and/or amino acid sequence analysis (see below). Peptides constitutively bound to SQ7 b were then purified from the affinity column eluate by acid denaturation followed by the separation of the low molecular weight peptides (acid- (Table 1) . Most strikingly, these peptides have a single residue, histidine, at the seventh sequencing cycle (P7, position of the residue in the peptide) and a hydrophobic residue at the ninth cycle (Table  1) . Further, only two to three different amino acid residues were detected at Pl, P2, and P3, therefore, these positions also appear somewhat more conserved. In contrast, P4, P5, P6, and P8 are degenerate, i.e., a number of different structurally unrelated amino acids are represented at these positions (Table 1 ). These data suggest that the SQ7 b molecules bind peptides and have a specific binding motif.
Peptides Constitutively Bound to SQa-2 Are Derived from Intracellular Proteins. Sequencing of the pool of peptides bound to MHC molecules provides only limited information, such as the binding motif and the overall heterogeneity of the ligands. To gain further insight into the physico-ch~fical properties of the peptides bound to SQ7 b, such as the number of different peptides bound and sources of these peptides, we have purified peptides (,,o2.7 nmol of the acid-eluted fraction) eluted from SQ7 b molecules by RP-HPLC and sequenced a number of individual peaks. Approximately 50 distinct peaks were resolved by this method (Fig. 2 A, solid line) and 36 peaks were collected by hand. Due to the high background in the first separation and to ensure purity of each peak, 16 of the 36 peaks (Fig. 2 A, arrows) were further separated individually by RP-HPLC. In several instances, this procedure resulted in further separation of the single peaks into two or three peaks (Fig. 2 B) .
A total of 18 individual sequences were derived from automated Edman sequencing of peaks indicated in Fig. 3 B because several of the peaks contained more than one peptide (Table 2) . A comparison of the individual peptide sequences with the pool peptide data (Table 1) shows general agreement between them (Table 3) . Almost all the individually sequenced peptides are nonameric (with the exception of peptide 10.1b [ Table 2 ], which is a decamer). Further, the peptides predominantly use histidine at P7 (12/18 peptides) and a hydrophobic residue at the COOH terminus, either at P9 or at Pl0 (predominantly leucine; Table 2 ). The remaining positions, including the somewhat conserved P2 and P3, are occupied most frequently by the same residues that were detected in the pool peptide sequence data ( Table 2 ). In addition, several amino acids that were not observed in the pool peptide sequences were detected in the individual pepticle sequences (Table 3) . Most notable of these are arginine, tyrosine, and alanine at P7, and methionine and glycine at P9 (Tables 2 and 3 ). The higher degree of degeneracy observed at all positions in the individual peptide sequence data may be due to the differences in the sensitivity between the two approaches.
A homology search against a protein data bank revealed 2 of the 18 peptides, peptides 19.1a and 25.2a, had a 100% match with abundantly expressed murine intracellular proteins, cofilin (an actin-binding protein; 29) and L19 (a 60S ribosomal protein; 30) ( Table 2 ). Both peptides represented major peaks in the RP-HPLC profile (Fig. 2 A) and were recovered with high yidd (19.1a, 49.2 pmol; 25.2a, 110.7  pmol) . None of the peptides have homology to serum proteins. This suggests that the SQa-2-associated peptides are derived from intracellular proteins of the host cell.
Native SQ7 ~ Is a Uniraolar Complex of Heavy and Light Chains and Peptid~
To approach the question of the stoichiometry of the Qa-2 heavy chain, light chain and peptides in the complex, we quantitated the a/~nity-purified SQ7 b molecules by sequence analysis. Amino add sequencing of the first 20 residues of the complex revealed that two types of heavy chains are present in almost equimolar amounts in the complex (not shown). One type (I) begins with a glycine residue at the NH2 terminus like almost all class I heavy chains (31) , while the other type (II) has two additional amino acid residues (Argl and Ala2) at the NH2 terminus, which is consistent with the previously reported data (32) .
We have used the yields of residues that occur in the two heavy chains of SQ7 b and flz-m to estimate the stoichiometry of the heavy and light chains in the class I complex. The choices of the residues used as markers for this analysis were based on the following criteria. (a) When identical residues were compared, they occurred in the heavy chain and fl2-m at different sequencing cycles; however, to have comparable yidds, the residues had to occur at dose posi-
Tablr 3. Compilation of Different Amino Acid Residues that Occur at a Given Position in Individual Peptides and Comparison to Pool Peptide Sequences
Position in the peptide
" Bold letters indicate amino acid assignments from pool peptide sequences (see Table 1 ). Number of times a residue appears at a given position on compiling the individual peptide sequences (see Table 2 ) is given in parenthesis.
tions in the heavy and the fight chains. (b) When two different residues were compared, they occurred in the same sequencing cycle, and their relative yidds, in general, are known to be very similar, e.g., leucine and isoleucine. Thus, the combined yields of the two heavy chains using residues Va112, Leu5, and Tyr7 for type I and Vail4, Lev7, and Tyr9 for type II heavy chains were compared to the yidds of residues Val9, Ile7, and Tyrl0 of/~2-m (Fig. 3 A) . The data demonstrated that the heavy chains are associated with the tight chain (/32-m) in unimolar ratio (Fig. 3 A) . Further, both the mouse and bovine /32-m are present in the complex in similar amounts as judged by the yields of their specific residues (data not shown). Amino acid sequence analysis was also used to quantitate the peptides bound to the SQ7 b molecules. For this quantitation, histidine was chosen as the marker residue because of the fact that it is the most common amino acid in the peptide at P7 (Table 2 ) and is not represented in the heavy or light chains at cycle 7. Histidine is present at cycle 9 in type I and at cycle 11 in type II SQ7 b heavy chains (32) but not in the peptide at these cycles (this report). This comparison revealed that PTHis represented ~65% of the yidd of histidines at cycles 9 and 11 of the two heavy chain sequences (Fig. 3 B) . Since histidine at P7 occurred in 12 of 18 peptides sequenced, and if this distribution reflects the average occurrence of this residue in the peptide" one would estimate peptide occupancy of "~97%.
In another experiment designed to address this issue, we have directly determined the molar amounts of the purified SQ7 b molecules and the acid-duted peptide fraction. To make this calculation, 2.5% of the starting amount of the affinity-purified heterotrimeric complex and 10% of the acidduted peptide fraction were quantitated by amino acid analysis. Using the yields of alanine, lencine" and arginine, it was determined that the affinity-purified starting material contained 5.75 nmol SQa-2 protein (see Materials and Methods). Similarly, using the yields of the conserved histidine and leudne residues in the peptides, it was determined that the acidduted ultrafiltrate contained ~53% molar yield of peptides expected from 5.75 nmol of SQ7 b molecules (see Materials and Methods) if there were 1:1 peptide/MHC stoichiometry. This is in good agreement with the value of ,v65% obtained from the sequence analysis of the trimolecular complex. Both these values represent lower estimates because histidine is not the only residue present at P7 in all the peptides. In fact, as mentioned above, since histidine is represented only in '~65% of the individually sequenced peptides (Table 2) , when corrected the actual value would be "~95%. Together, the data are consistent with the conclusion that the majority of the SQa-2 molecules are occupied by peptides at least to the extent seen with yidds for HLA-B27-associated peptides (33) . Thus, native SQ7 b molecules appear to be predominantly heterotrimers consisting of noncovalently associated heavy and light chains complexed with peptides in close to 1:1:1 stoichiometry.
Several Hundred Different Peptides Are Constitutively Bound to SQa-2 Molecules.
The properties of the peptides associated with SQ7 b suggest that they are very similar to those bound to class Ia molecules. Since individual class Ia molecules can bind a large variety of peptides of different but related sequences, somewhere in the range of 200 to >1,000 (34), we addressed the question of the size of the peptide repertoire that could associate with SQ7 b molecules. One estimate could be made by directly counting the number of peaks obtained from the two RP-HPLC chromatograms and the number of peptide sequences obtained per peak. The number of peptide peaks from the first RP-HPLC separation is "~50 (Fig. 2 A) . Several of these peaks on rechromatography yielded an average of two peaks (Fig. 2 B) , making the total number of resolvable peaks to be in the range of 100. Since, an average of two peptide sequences were obtained per peak (Table  2) , it is reasonable to conclude that at least 200 diverse peprides can bind to SQ7 b molecules. This would be a minimum estimate of the size of the peptide repertoire due to the semitivity of the analysis, which does not detect minor species ofpeptides that may be associated with the dass I molecules.
The above estimate is consistent with another calculation based on molar yidds of the total peptides in the Centricon 3 ultrafiltrate eluted from SQ7 ~ and the yields of individual peptides. If 3.03 nmol of the starting amount of peptides in the ultraf~trate contains 100 different peptides, then a single peptide that occupies 1.0% of SQ7 b should have a yield of 30.3 pmol. Since the majority (15/18) of the peptides sequenced were represented in amounts <30.3 pmol (range: 2.0-22.6 pmol, 0.07-0.7%; exceptions: peptide 19.1a, 1.6%; 25.2a, 3.6%; 25.2b, 1.4%), we conclude that SQ7 b molecules can bind >100 different peptides.
Discusslon
The availability of SQa-2 molecules in large amounts produced by genetically engineered mammalian cells allowed a thorough biochemical analysis of this molecule using sentitire techniques. Our data demonstrate that SQ7 b, an MHC class Ib molecule, constitutively binds several hundred different naturally processed peptides. In most respects, the properties of the bound peptides, such as the nonameric length, the presence of conserved residues at two positions, the intracdlular source of the peptides, and the minimum estimated number of different peptides that can bind Qa-2 molecules, are similar to MHC class Ia binding peptides.
A more refined understanding of the properties of the SQ7 b binding peptides was achieved by examining the individual peptide sequences than was possible from pool sequence data. The most striking similarity between the data obtained from the pool sequence and that of individual peptides is the restricted usage of histidine at P7 and the presence of a hydrophobic residue at the carboxy terminus (PC). Interestingly, but less frequently, arginine, tyrosine, and alanine were seen at P7. These residues were not represented in the pool sequences probably because the relative molar abundance (,,020% when the yields of the three residues are combined) of these amino acids may have been bdow the threshold of detection under the conditions used for pool sequencing. In contrast to the conserved amino acid usage at Pl, P2, and P3 deduced from the peptide pool sequencing, these positions show high sequence variability on analysis of individual sequences. Whereas Pl is genuinely structurally variable, P2 and P3 show a propensity for either a hydrophobic or a polar residue. Thus, P2 and P3 are probably moderately conserved positions. The remainder of the positions (P4, P5, P6, and P8) in the pepti& are &generate. Thus, the data for individual peptide sequences point out that the mechanism for pepti& MHC interaction is complex and simply knowing the aUde specific-motif is not sul~icient to predict the precise rules for pepti& binding.
Based on the structural motif of the SQ7 b binding peptides, we suggest that the side chains of residues at P7 and PC (Pg/P10) probably serve as specificity anchors for binding to SQ7 b deft. In addition to the dominant specificity anchors, side chains of residues at P2 and P3 may play the role of accessory or alternate anchors that may be required for the specificity and/or affinity for binding to SQ7 b. It should be noted that at least one of the conserved amino add residues (P2, Gln or Leu; P3, Leu or Asn), or a structuraUy related residue, is used at P2 and/or P3 in the peptides that lack the dominant PTHis anchor (Table 2) . Thus, in such peptides, P2 and/or P3 may play an important role in anchoring the peptide. On average, individual peptides contain only three of the four proposed anchors at P2, P3, PT, and P9. This is similar to the number of anchors observed in HLA-A3 binding peptides (35) . A unique feature of the SQ7 b binding motif is the fact that, besides the COOH-terminal anchor (PC), the dominant anchor at P7 of the peptide is located distally towards the COOH-terminal end of the pepti&. This is in striking contrast with all the known aUde-specific dominant anchor positions of mouse (36) (37) (38) and human (33-35, 39, 40) class Ia binding peptides and may be the consequence of the physico-chemical architecture of the Qa-2 groove.
Rotzschke et al. (41) have recently reported the sequence of peptide pool ehted from GPI-linked splenic and thymic Qa-2 complexes and proposed that "only a few different peptides are presented by these molecules" based on the assumption that each peptide uses four to five anchors for binding Qa-2. Furthermore, they suggested that Qa-2 functions as a restriction dement for peptides derived from gut-associated antigens. Whereas the sequence data reported for the peptide pool presented here and by P, otzschke et al. (41) are extremely similar, the two studies differ drastically in the qualitative and quantitative estimates of Qa-2 binding peptide repertoire. Using two approaches, we have determined empirically that a minimum of 200 different peptides can bind SQ7 b, a number similar to the minimum estimates of class Ia binding pepti& repertoire. Several other observations also support our conclusion. First, our data from individual peptide sequences demonstrate that only a subset of Qa-2 binding anchors at P2, P3, P7, and Ix) is present in individual peptides. This, we suggest, enables the binding of a large array of diverse peptides to Qa-2. Second, the function of the Qa-2 antigens in the immune response against gut-associated bacteria is inconsistent with the known tissue distribution of these molecules (expressed only in lymphoid derived cells; reference 3). Our computer searches of data banks using anchors at P7 and P9 together with auxiliary anchors at either P2 or P3 did not reveal homology to any particular group of proteins, pathogen derived or otherwise (Stroynowski, I., and B. Jameson, unpublished results). Third, if the criteria used by Rotzschke et al. (41) to define Qa-2 binding motif in the peptides were indeed correct, then their computer searches should have found peptides derived from cofilin and L19 (reported here), both of which are mouse proteins (29, 30) found in SwissProt, GenBank, and EMBL sequence data banks. Finally, the ability to express SQa-2 and GPI-Qa-2 in high amounts in a variety of transfected cells, including mydoma (this report), hepatomas, and L cells (18) , and CHO cells ('~baczewski, P., and I. Stroynowski, unpublished results). also argues against the contention that Qa-2 binding peptides are rare or limiting. Thus, Qa-2 molecules are not "receptors of higher stringency than ordinary class I molecules (41)" but they bind a large array of diverse peptides derived from endogenously synthesized and naturally processed proteins in much the same manner as the ordinary class I molecules.
